Gene therapy for peripheral vascular disease

Israel Medical Association Journal

Volumn 2, Issue 1, 2000, Pages 27-32

  Baumgartner, I ^a   Isner, J M ^a  

^a ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; Angiogenic growth factors; Arteriosclerosis; Peripheral vascular disease; Vascular endothelial growth factor

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; BINDING AFFINITY; CLINICAL TRIAL; GENE; GENE THERAPY; GENE TRANSFER; HEART MUSCLE REVASCULARIZATION; HUMAN; MITOGENICITY; NONHUMAN; PERIPHERAL VASCULAR DISEASE; RABBIT; RESTENOSIS; REVIEW;

AGED; AGED, 80 AND OVER; ARTERIOSCLEROSIS; ENDOTHELIAL GROWTH FACTORS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; LYMPHOKINES; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPHERAL VASCULAR DISEASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VASCULAR PATENCY;

EID: 0033838923     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Vasculogenesis and angiogenesis in embryonic stem cell-derived embryoid bodies
2. Failure of blood-island formation and vasculogenesis in flk-1-deficient mice
3. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
4. Isolation of putative progenitor endothelial cells for angiogenesis
5. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
6. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
7. Differentiation of endothelium
8. Mechanisms of angiogenesis
9. Molecular mechanisms of coronary collateral vessel growth
10. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factor
11. Enhanced revascularization of the ischemic limb by means of angiogenic therapy
12. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs
13. Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin
14. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
15. Hypoxia-induced paracrine regulation of VEGF receptor expression
16. Therapeutic angiogenesis: A single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model
17. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor
18. In vivo evidence that vascular endothelial growth factor stimulates collateral formation by inducing arterial cell proliferation in a rabbit ischemic hindlimb
19. Angiogenesis
20. Vascular permeability factor: A tumor-derived polypeptid that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration
21. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: Role of flt-1
22. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease
23. Direct gene transfer into mouse muscle in vivo
24. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion
25. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
26. Post-natal overexpression of vascular endothelial growth factor-C(VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia
27. Second European consensus document on chronic critical leg ischemia
28. Arterial gene transfer of naked DNA for therapeutic angiogenesis: Early clinical results
29. Clinical evidence of angiogenesis following arterial gene transfer of phVEGF165 in a patient with ischaemic limb
30. Constitutive expression of phVEGF165 following intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
31. Administration of culture-expanded endothelial progenitor cells (EPC) augments therapeutic neovascularization
32. Influence of vascular endothelial growth factor on diabetic retinopathy
33. Expression of vascular endothelial growth factor does not promote transformation but covers a growth advantage in vivo to Chinese hamster ovary cells
34. Cancer and atherosclerosis
35. A confidence profile analysis of the results of femoropopliteal percutaneous transluminal angioplasty in the treatment of lower-extremity ischemia
36. The endothelium as a regulator of vascular smooth muscle proliferation
37. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery
38. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries
39. Arterial gene therapy for restenosis
40. Arterial gene therapy for inhibitin restenosis in patients with claudication undergoing superficial femoral artery angioplasty